dexmedetomidine
dexmedetomidine: sourced relationships with 1 company · 23 clinical trials tracked.
dexmedetomidine evidence translation
What we can confirm
23 tracked trials
What it means
What to watch
Prepared research question
How could dexmedetomidine → BTAI affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence8 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| BioXcel Therapeutics, Inc. (BTAI) Agitation; Agitation,Psychomotor | Phase 3 |
Clinical Trial Registry Records (23)showing 10 most recent
An Alpha2-adrenoceptor Agonist to Reduce Locus Coeruleus Activity During Sleep in Adults With Insomnia Disorder: a Pilot Randomised Placebo-controlled Cross-over Study
Primary endpoint: Electrographic (EEG) signatures
Evaluation of an Opioid-Free Approach in Sedation Method Selection in Endoscopy Units: A Prospective Randomized Observational Double-Blind Comparison of Dexmedetomidine (Opioid-Free) and Remifentanil-Dexmedetomidine (Opioid-Based) Combination
Primary endpoint: Incidence of Opioid-Related Adverse Symptoms
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With a Sublingual Formulation of Dexmedetomidine (BXCL501)
Primary endpoint: Change in ASD Score
Dexmedetomidine Versus Fentanyl-Midazolam Combination to Attenuate the Stress Response in Laparoscopic Cholecystectomy
Primary endpoint: Hemodynamics
A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guided Infraclavicular Block
Primary endpoint: Motor block duration
Differences in C-Reactive Protein Levels Between Traumatic Brain Injury Patients Receiving Dexmedetomidine and Those Not Receiving Dexmedetomidine Undergoing Craniotomy at Prof. Dr. Margono Soekarjo Regional General Hospital, Purwokerto
Primary endpoint: Change in C-Reactive Protein (CRP) Levels
Efficacy of Dexmedetomidine Versus Midazolam Sedation on Extubation Time in Mechanically Ventilated Preterm Infants: a Randomized Controlled Multicenter Trial - DEXPRE
Primary endpoint: Time, measured in minutes, is evaluated from the discontinuation of the experimental treatment (either dexmedetomidine-based or midazolam-based sedation) to extubation.
Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm: Outpatient Follow-up of Mental Health INDices (SDATE OF MIND)
Primary endpoint: Post-traumatic stress disorder symptoms
Dexmedetomidine as an Adjuvant to Bupivacaine in Bilateral Pectoral Nerve Blocks for Postoperative Pain Control After Cardiac Surgeries: A Randomized Controlled Trial
Primary endpoint: The duration of analgesia
Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm
Primary endpoint: The primary outcome is a composite of the following: 1. All-cause in-hospital death AND/OR 2. Any in-hospital ventricular arrhythmia requiring treatment after study drug initiation.
Frequently asked questions
Which companies have sourced relationships with dexmedetomidine?
dexmedetomidine has dated SEC/FDA relationship records for BioXcel Therapeutics, Inc..
How many clinical trials involve dexmedetomidine?
BioSniper tracks 23 clinical trials involving dexmedetomidine.